Global Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)

Novo Nordisk

Market Cap: DKK 1.4t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

Pfizer

Market Cap: US$142.4b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Eli Lilly

Market Cap: US$946.3b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

Merck

Market Cap: US$249.9b

Operates as a healthcare company worldwide.

Johnson & Johnson

Market Cap: US$501.9b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

Bristol-Myers Squibb

Market Cap: US$108.6b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

AbbVie

Market Cap: US$393.8b

A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.

Canopy Growth

Market Cap: CA$793.9m

Engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia.

BioMarin Pharmaceutical

Market Cap: US$11.7b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Vertex Pharmaceuticals

Market Cap: US$113.5b

A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

AstraZeneca

Market Cap: UK£212.0b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Tilray Brands

Market Cap: US$1.4b

A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally.

Amicus Therapeutics

Market Cap: US$3.4b

A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.

Tempus AI

Market Cap: US$11.1b

Operates as a healthcare technology company.

Zoetis

Market Cap: US$54.1b

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.

Moderna

Market Cap: US$13.2b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

CSL

Market Cap: AU$84.5b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

Sanofi

Market Cap: €100.2b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Thermo Fisher Scientific

Market Cap: US$211.3b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

Incyte

Market Cap: US$19.1b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Telix Pharmaceuticals

Market Cap: AU$4.0b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.

GSK

Market Cap: UK£73.1b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Curaleaf Holdings

Market Cap: CA$3.4b

Produces and distributes cannabis products in the United States and internationally.

Green Thumb Industries

Market Cap: CA$2.6b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

Gilead Sciences

Market Cap: US$150.7b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Recursion Pharmaceuticals

Market Cap: US$2.3b

Operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States.

CRISPR Therapeutics

Market Cap: US$5.2b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

Illumina

Market Cap: US$19.9b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Aurora Cannabis

Market Cap: CA$421.9m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

Teva Pharmaceutical Industries

Market Cap: US$34.8b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Roche Holding

Market Cap: CHF 278.2b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Catalyst Pharmaceuticals

Market Cap: US$2.9b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

Cosmo Pharmaceuticals

Market Cap: CHF 1.6b

Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.

Bayer

Market Cap: €35.2b

Operates as a life science company worldwide.

Trulieve Cannabis

Market Cap: CA$2.0b

Operates as a cannabis retailer.

Amgen

Market Cap: US$174.7b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.